Gene · 6571
Papers3,040
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 3,040
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Structural insight into the glucose-6-phosphate transport by G6PT1 and inhibition mechanism of CGA. | Sci Adv | 2026 | 41616054 | PubTator, text mining | PubMed |
| Synaptic control of retinal ganglion cell survival and axon regeneration. | Mol Neurodegener | 2026 | 41606681 | PubTator, text mining | PubMed |
| An interactive cascaded deep learning framework with expert refinement for accurate striatal subregion segmentation. | Sci Rep | 2026 | 41606103 | PubTator, text mining | PubMed |
| [The diagnostic value of 18F-AV-133 VMAT2 hybrid PET-MRI for cognitive impairment in Parkinson's disease]. | Zhonghua Yi Xue Za Zhi | 2026 | 41588308 | PubTator, text mining | PubMed |
| Norepinephrine and dopamine Imbalance in the medial frontal gyrus from patients with Alzheimer's disease. | IBRO Neurosci Rep | 2026 | 41568198 | PubTator, text mining | PubMed |
| Neighborhood nonnegative matrix factorization identifies patterns and spatially-variable genes in large-scale spatial transcriptomics data. | Genome Biol | 2026 | 41546049 | PubTator, text mining | PubMed |
| Efficacy and Safety of VMAT2 Inhibitors in the Treatment of Huntington Disease: A Meta-Analysis of Randomized Clinical Trials. | Neurol Clin Pract | 2026 | 41540979 | PubTator, text mining | PubMed |
| Evaluation of the Relationship between Vesicular Monoamine Transporter 2 (VMAT2) Inhibition and Neurologic Adverse Events in Approved Drugs. | ACS Pharmacol Transl Sci | 2026 | 41536287 | PubTator, text mining | PubMed |
| Consultation-Liaison Case Conference: Stimulant-Induced Tardive Dyskinesia. | J Acad Consult Liaison Psychiatry | 2026 | 41349717 | PubTator, text mining | PubMed |
| Utility and limitations of the FDA adverse events reporting system public dashboard for safety analyses: a case study with vesicular monoamine transporter 2 inhibitors. | Expert Opin Drug Saf | 2026 | 41212745 | PubTator, text mining | PubMed |
| Identification of Hub Genes and Prediction of Interacting Chemicals in Parkinson's Disease Using Bioinformatics. | Curr Med Chem | 2026 | 40417757 | PubTator, text mining | PubMed |
| Disposition and effects of alpha-pyrrolidinoisohexanophenone (α-PHiP) in comparison with cocaine: an observational study. | Front Pharmacol | 2025 | 41614071 | PubTator, text mining | PubMed |
| Morphological and functional alterations in type 2 diabetes pancreata assessed with MRI-based metrics and [18F]FP-(+)-DTBZ PET. | Front Endocrinol (Lausanne) | 2025 | 41488139 | PubTator, text mining | PubMed |
| Pathogenic mechanism underlying parkinsonism induced by neurotoxicants (MPTP and 6-hydroxydopamine) and α-synuclein: a unifying hypothesis. | J Mol Cell Biol | 2025 | 41258873 | PubTator, text mining | PubMed |
| Valbenazine Sprinkle: An Alternative Formulation of Valbenazine for Oral Administration in Patients With Dysphagia. | Clin Transl Sci | 2025 | 41215526 | PubTator, text mining | PubMed |
| Molecular basis of vesicular monoamine transport and neurological drug interactions. | Cell Rep | 2025 | 41166311 | PubTator, text mining | PubMed |
| Valbenazine for the Treatment of Chronic Motor or Vocal Tic Disorder (CMVTD). | Cureus | 2025 | 41141210 | PubTator, text mining | PubMed |
| VMAT2 inhibitors for the treatment of tardive dyskinesia: a narrative review. | CNS Spectr | 2025 | 41122869 | PubTator, text mining | PubMed |
| Respiratory Dyskinesia With Refractory Tachypnea and Alkalosis Treated by Vesicular Monoamine Transporter 2 Inhibitor. | Chest | 2025 | 41073040 | PubTator, text mining | PubMed |
| Efficacy and safety of vesicular monoamine transporter 2 inhibitors for Huntington's disease chorea based on network meta-analysis. | Front Pharmacol | 2025 | 41069601 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6571/papers?page=4